Table 3. Univariate and multivariate analyses for disease free-interval in the validation set.
Variables | Univariate analysis |
Multivariate analysis |
||
---|---|---|---|---|
Relative Risk (95% CI) | p | Relative Risk (95% CI) | p | |
Age <=50 vs >50 years | 0.94 (0.45-1.98) | 0.873 | ||
Pathological size >20mm vs <=20mm | 1.11 (0.42-2.92) | 0.827 | ||
Grade II/III vs I | 2.12 (0.99-4.5) | 0.052 | 1.39 (0.52-3.70) | 0.515 |
PR status Negative vs Positive | 0.9 (0.38-2.1) | 0.805 | ||
Vascular invasion Yes vs No | 1.36 (0.55-3.36) | 0.512 | ||
KI67(IHC) >14 vs < 14% | 2.57 (1.16-5.68) | 0.020 | 1.39 (0.48-4.08) | 0.544 |
Genomic Grade GG3 vs GG1 | 2.59 (1,17-5.73) | 0.019 | 1.16 (0.39-3.48) | 0.788 |
IHC3 score (continuous) | 1.01 (1.00-1.01) | 0.204 | ||
Number of Breakpoints >34 vs <34 | 3.7 (1.73-7.92) | <0.001 | 3.47 (1.29-9.31) | 0.014 |
vs: versus.